BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 16754706)

  • 1. Probiotics and inflammatory bowel diseases.
    Bai AP; Ouyang Q
    Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
    Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
    Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
    Blum S; Schiffrin EJ
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):53-60. PubMed ID: 14503689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbes, intestinal inflammation and probiotics.
    Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
    Rioux KP; Madsen KL; Fedorak RN
    Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
    [No Abstract]   [Full Text] [Related]  

  • 6. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health, probiotics, and inflammation.
    Mengheri E
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S177-8. PubMed ID: 18685508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenic role of intestinal flora in IBD and colon cancer.
    Rescigno M
    Curr Drug Targets; 2008 May; 9(5):395-403. PubMed ID: 18473768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-bacterial interactions in inflammatory bowel disease.
    Mahida YR; Rolfe VE
    Clin Sci (Lond); 2004 Oct; 107(4):331-41. PubMed ID: 15212627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
    Andoh A; Fujiyama Y
    World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis.
    Sartor RB
    Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():17-22; discussion 22-3. PubMed ID: 9467975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
    Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
    World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics and prebiotics in chronic inflammatory bowel diseases.
    Ewaschuk JB; Dieleman LA
    World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recipe for IBD: can we use food to control inflammatory bowel disease?
    Witkowski M; Witkowski M; Gagliani N; Huber S
    Semin Immunopathol; 2018 Feb; 40(2):145-156. PubMed ID: 29124320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
    Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
    J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.
    Chichlowski M; Hale LP
    Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1139-49. PubMed ID: 18927210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics and immune regulation of inflammatory bowel diseases.
    Cong Y; Konrad A; Iqbal N; Elson CO
    Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):145-54. PubMed ID: 14561167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.